VPS26C

Across TCGA pan-cancer cohorts, VPS26C mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of VPS26C’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where VPS26C mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types VPS26C is over-expressed in tumor, although a few such as CCRCC and COAD show the opposite, repressed pattern.

CCRCC, COAD, and LUAD are the cancer types where VPS26C tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VPS26C mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	II,III,IV	−0.484	<.001	11	view →
COAD	Male	III,IV	−0.483	<.001	11	view →
LUAD	Male	All	−0.286	<.001	9	view →
LSCC	Male	All	−0.589	<.001	8	view →
HNSC	Male	All	−0.260	<.001	8	view →
PDAC	Male	All	+0.286	.003	3	view →
OV	All	All	−0.271	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

VPS26C–CCRCC

Open the CCRCC breakdown →